Correlation Ventures

Correlation Ventures Research Investment Thesis Correlation Ventures is an analytics-driven venture capital firm that leverages proprietary data science and predictive modeling to identify exceptional investment opportunities and make rapid investment decisions. Founded by Trevor Kienzle and David Coats, the firm combines world-class AI analytics with industry-leading networks to enable entrepreneurs to secure funding efficiently. The firm's core philosophy is democratizing venture capital through data-driven decision making. They believe venture returns are highly right-skewed and that the ability to rapidly identify and fund high-potential companies is a competitive advantage. Their tagline "Rapid Decisions. Lasting Value" encapsulates their approach: investment decisions within days to two weeks, without unnecessary hurdles. Investment Approach Correlation Ventures operates as a co-investor alongside lead investors, writing flexible checks across 100+ companies while avoiding board seats and operational friction. This co-investor model allows them to deploy capital quickly without the overhead of traditional board governance. Key aspects of their approach: Rapid decision-making : Investment decisions made within days to two weeks Data-driven analysis : Proprietary predictive model and world's most complete VC dataset Network leverage : Industry-leading networks for founder introductions and market insights Co-investment model : Partners with other investors, rarely leads rounds Minimal friction : No board seats, flexible check sizes, efficient process Stage Focus Correlation Ventures focuses primarily on: Seed stage : $1M-$4M check sizes typical Series A : Selective investments Pre-Seed : Small checks for promising teams They invest across all stages but are most active in seed and early-stage rounds. Check Size Typical investment range: $100K-$4M Pre-Seed: $100K-$500K Seed: $1M-$4M Series A: Selective participation Their flexible check size model allows them to scale investment with company needs and market conditions. Lead Tendency Correlation Ventures operates as a co-investor , not a lead investor. They explicitly avoid: Leading rounds Taking board seats Managing round processes Instead, they function as a capital partner alongside established lead investors, providing fast follow-on capital and network introductions. Recent Activity The firm is actively deploying capital from Correlation Fund III ($130M raised in June 2023, part of their $500M total AUM). Recent investments (2025-2026): February 2026: BizTrip (travel AI platform, $1.5M pre-seed) January 2026: AeroRx (COPD therapy, $21M alongside Avalon BioVentures) October 2025: AiPrise ($12.5M) September 2025: Neura Health ($11.4M) September 2025: AeroRx ($21M) The firm has an exceptionally active portfolio with 200+ companies, indicating consistent deployment of capital across multiple rounds. Fund Status Fund III : $130M (closed June 2023), actively deploying Total AUM : ~$500M across multiple funds Status : Actively deploying, regularly adding companies to portfolio Portfolio Composition Portfolio companies span diverse sectors: Consumer : Casper (IPO), Personal Capital (acquired), Lemonaid Health (acquired), Carewell (acquired), Gabi (acquired) Enterprise Software : Zebit (IPO), IonQ (IPO), MosaicML (acquired), AlienVault (acquired), Compass (acquired), Distil (acquired) Biopharma : Synthorx (acquired), ORIC (IPO), Janux (IPO), Galera (IPO) Aerospace : Astra (IPO), AeroRx (clinical stage) Other sectors : Neon (acquired software), Dizzion (enterprise), and 190+ additional companies Notable outcomes: IPOs : Upstart, IonQ, Janux, Casper, Astra, Galera, ORIC, Zebit Acquisitions : Synthorx, MosaicML, Personal Capital, Neon, AlienVault, Lemonaid Health, Gabi, Carewell, Compass, Distil, Dizzion Team Leadership: Trevor Kienzle, Managing Director & Co-Founder : Co-founder of Correlation Ventures, data science and venture strategy background David Coats, Managing Director & Co-Founder : Co-founder, active in Medium publication contributing data-driven venture insights Investment & Analytics: Anu Pathria, Ph.D., Managing Director Analytics : Leads analytics strategy Moiz Saifee, Partner, Analytics : Specializes in data-driven analysis Wesley Barrow, Partner : Investment partner Operations & Advisory Board: Grace Chui-Miller, Finance Partner Zainab Ali, Data Engineer Megha Bothera, Senior Analyst Advisory Board: Krishna Gopinanathan (Applied Data Finance), Matthew Rhodes-Kropf (MIT Sloan), Steven Neil Kaplan (University of Chicago), Michael Ewens (Caltech), Michael Thiemann (Global Analytics Holdings) Decision Process & Timeline Decision Process : Partnership-driven with analytics support; data informs but doesn't determine decisions Timeline : Days to 2 weeks (exceptionally fast compared to industry standard of 4-8 weeks) Committee : Partnership-based review with analytics team input Warm Introductions Warm introductions preferred but not strictly required. Their network of entrepreneurs and investors enables introductions, and their rapid decision-making makes the process less dependent on traditional gatekeeping. Typical Involvement Board Seat : No (explicitly avoided) Observer Rights : Possible but not standard Advisor Role : Occasional, leveraging network connections Post-investment : Periodic check-ins, network introductions, follow-on funding decisions Founder Preferences While not explicitly stated, Correlation Ventures' portfolio reveals preferences for: Experienced founders : Multiple exits in portfolio indicate backing of repeat entrepreneurs Technical depth : Strong presence in complex tech (biotech, quantum computing, aerospace) Diversified backgrounds : Consumer to deep science Data-driven thinking : Align with Correlation's analytical approach Geographic Focus Primarily US-based with: Strong presence in San Francisco Bay Area Significant activity in San Diego (firm headquarters) East Coast presence (New York, Boston area from portfolio) Selective international investments in developed markets Sector Preferences Based on portfolio analysis: Enterprise Software : 30% of portfolio (largest sector) Biopharma & Biotech : 20% (clinical stage and earlier) Consumer Apps & E-commerce : 20% Financial Services : 10% Healthcare Digital : 10% Food & Agriculture : 5% Media & Entertainment : 5% Notably broad across sectors, indicating sector-agnostic investment philosophy ("great companies, no matter what they do"). Technology & Model Preferences B2B SaaS : Strong representation in portfolio AI/Machine Learning : Active in consumer and enterprise AI applications Data Analytics : Natural given firm's analytics background Biotech & Life Sciences Tech : Significant exposure Deep Tech : Aerospace and advanced materials Consumer Applications : Mobile and digital consumer products Notable Exits & Track Record IPOs (8 from portfolio): Upstart (AI lending), IonQ (quantum computing), Janux (biopharma), Casper (direct-to-consumer mattresses), Astra (small satellites), Galera (oncology), ORIC (oncology), Zebit (consumer credit) Major Acquisitions (10+): Synthorx (genetic engineering, acquired), MosaicML (AI infrastructure, acquired), Personal Capital (wealth management, acquired), AlienVault (cybersecurity, acquired) Data-Driven Philosophy Correlation Ventures publishes data-driven insights on venture capital through their Medium publication "VC by the Numbers." Recent articles discuss: IPO window dynamics and market timing Risk-return relationships in venture Distribution of venture outcomes (right-skewed, not 80/20) Founder quality indicators This thought leadership demonstrates the firm's commitment to advancing venture capital through data and analytics. Summary Correlation Ventures represents a modern, analytics-driven approach to venture capital. With $500M AUM and 200+ portfolio companies, the firm has demonstrated the ability to identify and fund successful companies across diverse sectors. Their rapid decision-making, co-investment model, and data-driven approach make them particularly attractive to founders seeking quick capital decisions without board-level friction. The firm's track record of exits (8 IPOs, 10+ major acquisitions) validates their thesis that data-informed decision-making yields superior returns.